
Cancer Matters with Dr. Bill Nelson – Cancer Genomics
Our next Cancer Matters podcast is now online. Today, Dr Bill Nelson talks with Dr Srinivasan Yegnasubramanian about his research into cancer genomics. In this preview, Dr Yegnasubramanian explains how genes work. To listen, click here: http://bit.ly/2nYZcRy
Clinton ⋅ Bill Nelson, Cancer Matters, Genes, Genomics, Johns Hopkins Kimmel Cancer Center, podcast, Research, Srinivasan Yegnasubramanian ⋅

Cancer Matters with Dr. Bill Nelson – Pathology
In this podcast from Johns Hopkins Kimmel Cancer Center Director Dr Bill Nelson, he talks to Dr Angelo De Marzo about the role of a pathologist in diagnosing a disease as well as his findings affirming the inconsistent use of research antibodies. In this preview, Dr De Marzo explains how antibodies are used in a lab and […]
Clinton ⋅ Angelo De Marzo, Anitbodies, Cancer Matters, Dr Bill Nelson, Johns Hopkins Kimmel Cancer Center, pathology, podcast, Research ⋅

Cancer Interception: Kimmel Experts Part of New Stand Up To Cancer Project
Stand Up To Cancer launched four new teams aimed at detecting and treating cancer in its earliest stages. Lung cancer expert Julie Brahmer, M.D., is the lead investigator for Johns Hopkins for lung cancer studies based at the Kimmel Cancer Center Thoracic Center of Excellence she directs. Victor Velculescu, M.D., Ph.D., an expert in the […]
Michelle Potter ⋅ lung cancer, Research, stand up to cancer, treatment, Treatments ⋅
Creativity Competition Creates New Ideas to Cure Cancer
Last Friday, the historic Hurd Hall at Johns Hopkins was filled to capacity with students, faculty and staff waiting to hear five scientists – all in the early part of their careers – describe their novel ideas on how to cure metastatic cancer. It was part of a competition on creative thinking named for John […]
admin ⋅ cancer research, metastatic cancer, Research, Science, vw ⋅
What Matters to You?
It was the culmination of years of effort by many scientists and physicians and the bravery of patients to try something new that has brought some steady hope in an experimental therapy called epigenetics.